Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AVR

Anteris Technologies Global Corp

Jun 08 • 12:23PM ET

9.36

-0.28 -2.85 %

Healthcare • Medical Instruments & Supplies • USA • Small • NASD

Today, 6:05 AMAnteris Technologies gets full ANSM clearance for DurAVR PARADIGM pivotal trial in France

Peers: ICUI EW MMSI TFX BAX BDX BSX MDT SYK MASI

| Held by: IWM IWO VXF VTWO IWC VTWG RSSL FSCC AVSC FSYD

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.22	Insider Own	16.51%	Shs Outstand	97.23M	Perf Week	2.91%
Market Cap	911.61M	Forward P/E	-	EPS next Y	-1.12	Insider Trans	45.31%	Shs Float	81.27M	Perf Month	43.86%
Enterprise Value	632.10M	PEG	-	EPS next Q	-0.21	Inst Own	67.85%	Short Float	5.15%	Perf Quarter	57.93%
Income	-95.30M	P/S	492.76	EPS this Y	54.29%	Inst Trans	9.68%	Short Ratio	4.03	Perf Half Y	106.28%
Sales	1.85M	P/B	3.27	EPS next Y	4.12%	ROA	-53.92%	Short Interest	4.19M	Perf YTD	87.68%
Book/sh	2.86	P/C	3.22	EPS next 5Y	31.55%	ROE	-59.25%	52W High	10.14 -7.64%	Perf Year	97.57%
Cash/sh	2.91	P/FCF	-	EPS past 3/5Y	-44.21% -	ROIC	-33.93%	52W Low	2.85 228.60%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-15.77% -	Gross Margin	-9.33%	Volatility	7.72% 7.32%	Perf 5Y	-
Dividend TTM	-	EV/Sales	341.68	EPS Y/Y TTM	2.38%	Oper. Margin	-5192.92%	ATR (14)	0.56	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	20.93	Sales Y/Y TTM	-25.74%	Profit Margin	-5148.78%	RSI (14)	66.47	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	20.93	EPS Q/Q	54.31%	SMA20	11.44%	Beta	1.58	Target Price	13.78
Payout	-	Debt/Eq	0.01	Sales Q/Q	-11.15%	SMA50	36.67%	Rel Volume	0.66	Prev Close	9.64
Employees	174	LT Debt/Eq	0.01	Earnings	May 12 AMC	SMA200	70.62%	Avg Volume	1.04M	Price	9.36
IPO	Dec 13, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	-3.40% -35.57%	Trades		Volume	322,015	Change	-2.85%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-12-26	Resumed	Cantor Fitzgerald	Overweight	$15
Mar-11-26	Initiated	Wells Fargo	Overweight	$16
Jan-08-25	Initiated	Lake Street	Buy	$20
Jan-07-25	Initiated	TD Cowen	Buy	$15
Jan-07-25	Initiated	Cantor Fitzgerald	Overweight	$9
Jan-07-25	Initiated	Barclays	Overweight	$22

Today 06:00AM	Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance (GlobeNewswire)
May-13-26 08:39AM	Anteris Appoints Susan Knight and Stephen Denaro to its Board of Directors (GlobeNewswire)
May-12-26 09:33PM	Anteris adds Susan Knight, Stephen Denaro to board as company advances heart valve strategy (Proactive)
07:43PM	Anteris advances PARADIGM trial as Q1 cash burn reflects commercialisation push (Proactive)
07:00PM	Anteris Announces Results for the First Quarter of 2026 (GlobeNewswire)
09:45PM	Loading…
May-06-26 09:45PM	Anteris treats first US patients in DurAVR pivotal trial (Proactive)
09:45PM	Anteris secures US Medicare coverage for PARADIGM Trial as DurAVR study advances (Proactive)
01:40PM	Anteris Technologies enrolls First US patients in global PARADIGM trial for DurAVR heart valve (Proactive)
May-05-26 08:11PM	Small Cap Watch: Small Ordinaries edges higher as company news flow continues (Proactive)
06:00AM	Anteris Technologies Announces First U.S. Patients Treated in Global Pivotal PARADIGM Trial (GlobeNewswire)
Apr-28-26 06:00AM	Anteris Technologies Secures CMS Reimbursement Supporting U.S. Site Activation for PARADIGM Trial (GlobeNewswire)
Apr-01-26 11:47PM	A new valve, a new playbook: How Anteris is trying to reshape a $10B heart market (Proactive)
Mar-05-26 05:03AM	Anteris Technologies Global Highlights DurAVR TAVR Data, PARADIGM Pivotal Trial Plans at TD Cowen Conference (MarketBeat)
Feb-26-26 06:41PM	Anteris reports US$77.8m 2025 net operating cash outflow as PARADIGM trial gets underway (Proactive)
06:00PM	Anteris Reports 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
06:30AM	Loading…
Feb-23-26 06:30AM	Anteris to Present at Healthcare Investor Conferences TD Cowen and Barclays (GlobeNewswire) +8.45%
Jan-24-26 09:01AM	Anteris Technologies price target lowered to $15 from $20 at Lake Street (TipRanks)
Jan-22-26 04:02PM	Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital Raises (GlobeNewswire) +8.42%
04:01PM	Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock (GlobeNewswire)
11:28AM	Anteris Technologies announces $200M public offering to fund clinical growth (Proactive)
Jan-21-26 05:50AM	Medtronic to buy up to $90M stake in heart valve developer Anteris (MedTech Dive) +5.39%
01:38AM	What Sparked Anteris Technologies (AVR) Stock Surge Over 52% After-Hours? (Benzinga)
Jan-20-26 10:53PM	Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering (GlobeNewswire) +12.52%
04:01PM	Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic (GlobeNewswire)
Nov-17-25 06:00AM	Anteris Technologies Presents Data from 100 DurAVR THV Patients at PCR London Valves (GlobeNewswire)
Nov-12-25 05:52PM	Anteris Announces Results for the Third Quarter of 2025 (GlobeNewswire)
Nov-03-25 07:00AM	FDA Approves Anteris's DurAVR THV Global Pivotal Trial (the "PARADIGM Trial") (GlobeNewswire)
Oct-28-25 06:08PM	Anteris DurAVR THV Demonstrates Favorable Hemodynamics in Small Annuli Patients with no Valve Related Mortality at One Year (GlobeNewswire) -7.84% -8.71%
Oct-27-25 05:43PM	Anteris Technologies Announces First Patients Treated in DurAVR THV Global Pivotal Trial (the "PARADIGM Trial") (GlobeNewswire)
08:43AM	Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR THV to be Presented at TCT 2025 (GlobeNewswire)
09:18AM	Loading…
Oct-15-25 09:18AM	Anteris Receives First European Regulatory Clearance to Commence DurAVR THV Global Pivotal Trial (the "PARADIGM Trial") (GlobeNewswire)
Sep-19-25 02:30AM	Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders (GlobeNewswire)
Sep-11-25 08:50AM	Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders (GlobeNewswire)
Sep-04-25 01:42AM	Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders (GlobeNewswire)
Aug-11-25 04:52PM	Anteris Announces Results for the Second Quarter of 2025 (GlobeNewswire) +6.00%
Jul-29-25 10:23AM	Anteris (AVR) Welcomes Two Directors as Major Trial Approaches (Insider Monkey)
Jun-09-25 10:52PM	Anteris Appoints David Roberts and Gregory Moss to its Board of Directors (GlobeNewswire) +13.29%
May-13-25 05:45PM	Anteris Announces Results for the First Quarter of 2025 (GlobeNewswire) -9.89%
Mar-31-25 07:15AM	Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR THV (GlobeNewswire)
Mar-21-25 07:30AM	Anteris Reports One-Year Patient Outcomes for DurAVR THV (GlobeNewswire) -10.16%
Mar-12-25 08:33PM	Anteris Reports 2024 Financial Results and Provides Corporate Update (GlobeNewswire) -6.18%
Feb-28-25 08:00AM	Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays (GlobeNewswire)
Dec-16-24 07:49PM	Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering (Business Wire)
Dec-12-24 10:34PM	Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering (Business Wire)

Anteris Technologies Global Corp. is a structural heart company, which engages in the development and commercialization of medical devices for heart diseases. It operates through the following geographical segments: United States, Germany, Australia, Switzerland, and Sweden. The company was founded in 1999 and is headquartered in Eagan, MN.

Vice Chairman & CEOMr. Wayne Geoffrey Paterson

President & DirectorMr. David St. Denis

Chief Financial OfficerMr. Matthew McDonnell

M.P.H.Dr. Chris Meduri M.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Knight Susan Elizabeth	Director	Jun 02 '26	Buy	9.29	11,000	102,228	11,000	Jun 04 06:01 PM
L1 Capital Pty Ltd	10% Owner	Jan 22 '26	Buy	5.75	5,000,000	28,750,000	13,219,814	Feb 09 08:49 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AVR

Anteris Technologies Global Corp

Upgrade your Finviz experience